Insider Trading28 Sept 2026, 10:55 am
Aarti Pharmalabs Closes Trading Window for Q2 FY27 Results
AI Summary
Aarti Pharmalabs Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from October 1, 2026, until 48 hours after the declaration of the financial results for the quarter ending September 30, 2026. All designated and connected persons have been informed. The date of the board meeting to approve these results will be communicated separately.
Key Highlights
- Trading window closed from Oct 1, 2026, for Q2 FY27 results.
- Closure is in line with SEBI Insider Trading Regulations.
- Applies to all designated and connected persons.
- Company to announce board meeting date for results approval soon.
Price Impact
More from AARTIPHARM